Literature DB >> 8079825

Osteoporosis from the point of view of the clinical endocrinologist.

J Szũcs1.   

Abstract

The physiology of the bone tissue is reviewed from the point of view of a clinical endocrinologist. The effect of the main calcium-regulating hormones and various local factors on the osteoblasts and osteoclasts is discussed. The aim of this review is to summarize the physiological and pathophysiological role of calcitonin, parathormone, vitamin D3, thyroid hormones, glucocorticoids, growth hormone and sex hormones on bone metabolism. The significance of endocrinological dysfunctions in the pathogenesis of osteoporosis, the most wide-spread metabolic bone disease, is emphasized. A theory concerning the pathogenetic role of androgen hormone deficiency in postmenopausal osteoporosis is discussed in detail.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079825     DOI: 10.1007/bf01986398

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  11 in total

1.  STUDIES ON POSTMENOPAUSAL OSTEOPOROSIS. I. URINARY EXCRETION OF 17-KETOSTEROID FRACTIONS IN POSTMENOPAUSAL OSTEOPOROSIS.

Authors:  I HOLLO; T FEHER
Journal:  Acta Med Acad Sci Hung       Date:  1964

2.  Evidence of estrogen receptors in normal human osteoblast-like cells.

Authors:  E F Eriksen; D S Colvard; N J Berg; M L Graham; K G Mann; T C Spelsberg; B L Riggs
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  [Androgens and bone metabolism].

Authors:  M Szathmári; I Holló
Journal:  Dtsch Med Wochenschr       Date:  1993-02-12       Impact factor: 0.628

4.  Decreased calcitonin reserve in accelerated postmenopausal osteoporosis.

Authors:  J Zséli; J Szücs; K Steczek; M Szathmári; E Kollin; C Horváth; M Guoth; I Holló
Journal:  Horm Metab Res       Date:  1985-12       Impact factor: 2.936

5.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

6.  Calcitonin secretion in streak gonad syndrome (Turner's syndrome).

Authors:  J Zseli; P Bosze; F Szalay; J Szucs; C Horvath; E Kollin; M Szathmari; J Laszlo; I Hollo
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

7.  Effect of intravenous calcium load on the serum calcium level in postmenopausal osteoporosis (a study of the pathogenesis, and diagnostic use of the test).

Authors:  I Holló; F Szalay; K Steczek; J Szücs
Journal:  Acta Med Acad Sci Hung       Date:  1978

8.  Effects of prolonged aminoglutethimid and dehydroepiandrosterone treatment on rat bones.

Authors:  M Boross; E Morava; I Gergely; I Holló
Journal:  Aktuelle Gerontol       Date:  1983-01

9.  Specific binding of parathyroid hormone to living osteoclasts.

Authors:  N Agarwala; C V Gay
Journal:  J Bone Miner Res       Date:  1992-05       Impact factor: 6.741

10.  Dehydroepiandrosterone sulphate and bone mineral density.

Authors:  M Szathmári; J Szũcs; T Fehér; I Holló
Journal:  Osteoporos Int       Date:  1994-03       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.